New asthma clinical trial: A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen

Published on: December 05, 2019 at 07:00PM
Condition:   Asthma
Interventions:   Drug: AZD8154 nebulizer suspension, 20 mg/mL;   Drug: Placebo
Sponsors:   AstraZeneca;   Parexel
Not yet recruiting